In vitro-in vivo myotoxicity of intramuscular liposomal formulations

Pharmaceutical Research

Volumn 13, Issue 9, 1996, Pages 1384-1388

  Al Suwayeh, Saleh A ^a   Tebbett, Ian R ^a   Wielbo, Donna ^a   Brazeau, Gayle A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

and creatine kinase; intramuscular; liposomes; loxapine; muscle damage; myotoxicity

Indexed keywords

LOXAPINE; LOXAPINE SUCCINATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG FORMULATION; ENCAPSULATION; IN VITRO STUDY; IN VIVO STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MYALGIA; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029856150     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016082218942     Document Type: Article

References (15)

1. O. Svendson. Local muscle damage and oily vehicles: A study on local reaction in rabbits after intramuscular injection of neuroleptic drugs in aqueous or oily vehicles. Acta. Pharm. et. Toxicol. 52:298-304 (1983).
2. F. Kadir, W. M. C. Eling, D. Abrahams, J. Zuidema, and J. A. Crommelin. Tissue reaction after intramuscular injection of liposomes in mice. Int. J. Clin. Pharmacol Ther. Toxic. 30:374-382 (1992).
3. J. A. Jackson. Intramuscular absorption and regional lymph uptake of liposome-entrapped inulin. Drug Metab. Dispos. 9:535-540 (1981).
4. E. Yoshida, and T. Nakae, Cytolytic activity of liposomes containing stearylamine. Biochem. Biophys. Acta. 854:93-101 (1986).
5. E. Arakawa, Y. Imai, H. Kobayashi, K. Okumura, and H. Sezaki. Application of drug-containing liposomes to the duration of the intramuscular absorption of water-soluble drugs in rats. Chem. Pharm. Bull. 23:2218-2222 (1975).
6. G. Chellman, L. Lollini, A. Dorr, and L. DePass. Comparison of ketorolac tromethamine with other injectable nonsteroidal anti-inflammatory drugs for pain-on-injection and muscle damage in the rat. Hum. Exp. Toxicol. 13:111-117 (1994).
7. C. Surber, and H. Sucker. Tissue Tolerance of intramuscular injectables and plasma enzyme activities in rats. Pharm. Res. 4:490-494 (1987).
8. C. Surber and U. Dubach, Tests for local toxicity of intramuscular drug preparation. Comparison of in vivo and in vitro findings. Arzneim.-Forsch./Drug Res. 39:1586-1589 (1989).
9. M. Olling, K. VanTwillert, P. Wester, A. B. T. Boink, and A. G. Rauws, Rabbit model for estimating relative bioavailability, residues and tissue tolerance of intramuscular products: comparison of two ampicillin products. J. Vet. Pharmacol. Ther. 18:34-37 (1995).
10. M. Aktas, D. Augusta, D. Concordet, P. Vinclair, H. Letebvre, P. L. Toutain, J. B. Braun. Creatine kinase in dog plasma: preanalytical factors of variation, reference values and diagnostic significance. Res. Vet. Sci. 56:30-36 (1994).
11. D. W. Fry, J. C. White, and I. D. Goldman. Rapid seperation of low molecular solutes from liposomes without dilution. Anal. Biochem. 90:809-815 (1978).
12. S. Cheung. S. Tang, and G. Remington. Simultaneous quantitation of loxapine, amoxapine and their 7- and 8-hydroxy metabolites in plasma by high-performance liquid chromatography. J. Chromatogr. 564:213-221 (1991).
13. G. A. Brazeau, and H-L. Fung. An in vitro model to evaluate muscle damage following intramuscular injection. Pharm. Res. 6:167-179 (1989).
14. G. A. Brazeau and C. A. White. Use of an in vivo model to evaluate muscle damage from intramuscular (IM) injections. Pharm. Res. 8:S168 (1992).
15. H. A. C. Titulaer, W. M. C. Eling, D. J. A Crommelin., P. A. M. Peeterst., and J. Zuidema. The parenteral controlled release of chloroquine in mice. J. Pharm. Pharmacol. 42:529-532 (1990).